CLRB - Cellectar Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
-
-
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
7,858
6,835
9,466
4,750
Selling General and Administrative
5,145
4,820
4,135
4,699
Total Operating Expenses
13,003
11,655
13,601
9,450
Operating Income or Loss
-13,003
-11,655
-13,601
-9,450
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-1,589
-1,613
22
3,262
Income Before Tax
-14,541
-13,239
-13,562
-6,180
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-14,541
-13,239
-13,562
-6,180
Net Income
-14,541
-13,239
-13,562
-6,180
Net Income available to common shareholders
-14,541
-15,481
-15,011
-6,180
Reported EPS
Basic
-
-5.23
-10.70
-13.60
Diluted
-
-5.23
-10.70
-13.60
Weighted average shares outstanding
Basic
-
2,962
1,403
454
Diluted
-
2,962
1,403
454
EBITDA
-
-11,573
-12,055
-9,093